Carregant...
Current status of autologous stem cell transplantation for multiple myeloma
More than 30 years after its introduction, autologous stem cell transplantation (ASCT) remains the standard of care for young patients with newly diagnosed multiple myeloma. Not only did the arrival of novel agents such as immunomodulatory drugs (IMiDs), proteasome inhibitors (PI) and monoclonal ant...
Guardat en:
| Publicat a: | Blood Cancer J |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6453900/ https://ncbi.nlm.nih.gov/pubmed/30962422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-019-0205-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|